Aquestive therapeutics provides business update and announces chief medical officer appointment

Warren, n.j., june 29, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (the “company” or “aquestive”), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today provided an update on recent business developments and announced the appointment of carl n. kraus, m.d. as chief medical officer of the company.
AQST Ratings Summary
AQST Quant Ranking